AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53
PHASE-I STUDY OF THE PHARMACOKINETICS OF A RADIOIMMUNOCONJUGATE, Y-90T101, IN PATIENTS WITH CD5-EXPRESSING LEUKEMIA AND LYMPHOMA
Authors: FOSS FM RAUBITSCHECK A MULSHINE JL FLEISHER TA REYNOLDS JC PAIK CH NEUMANN RD BOLAND C PERENTESIS P BROWN MR FRINCKE JM LOLLO CP LARSON SM CARRASQUILLO JA
Citation: Fm. Foss et al., PHASE-I STUDY OF THE PHARMACOKINETICS OF A RADIOIMMUNOCONJUGATE, Y-90T101, IN PATIENTS WITH CD5-EXPRESSING LEUKEMIA AND LYMPHOMA, Clinical cancer research, 4(11), 1998, pp. 2691-2700
HIGH-DOSE VERSUS LOW-DOSE FLUDARABINE IN THE TREATMENT OF PATIENTS WITH SEVERE REFRACTORY RHEUMATOID-ARTHRITIS
Authors: DAVIS JC FESSLER BJ TASSIULAS IO MCINNES IB YARBORO CH PILLEMER S WILDER R FLEISHER TA KLIPPEL JH BOUMPAS DT
Citation: Jc. Davis et al., HIGH-DOSE VERSUS LOW-DOSE FLUDARABINE IN THE TREATMENT OF PATIENTS WITH SEVERE REFRACTORY RHEUMATOID-ARTHRITIS, Journal of rheumatology, 25(9), 1998, pp. 1694-1704
ABNORMAL REGULATION OF INTERFERON-GAMMA, INTERLEUKIN-12, AND TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN INTERFERON-GAMMA RECEPTOR-1 DEFICIENCY
Authors: HOLLAND SM DORMAN SE KWON A PITHAROWE IF FRUCHT DM GERSTBERGER SM NOEL GJ VESTERHUS P BROWN MR FLEISHER TA
Citation: Sm. Holland et al., ABNORMAL REGULATION OF INTERFERON-GAMMA, INTERLEUKIN-12, AND TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN INTERFERON-GAMMA RECEPTOR-1 DEFICIENCY, The Journal of infectious diseases, 178(4), 1998, pp. 1095-1104
HISTAMINE POTENTLY SUPPRESSES HUMAN IL-12 AND STIMULATES IL-10 PRODUCTION VIA H2 RECEPTORS
Authors: ELENKOV IJ WEBSTER E PAPANICOLAOU DA FLEISHER TA CHROUSOS GP WILDER RL
Citation: Ij. Elenkov et al., HISTAMINE POTENTLY SUPPRESSES HUMAN IL-12 AND STIMULATES IL-10 PRODUCTION VIA H2 RECEPTORS, The Journal of immunology (1950), 161(5), 1998, pp. 2586-2593
A PILOT-STUDY OF 2-CHLORO-2'-DEOXYADENOSINE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED GLOMERULONEPHRITIS
Authors: DAVIS JC AUSTIN H BOUMPAS D FLEISHER TA YARBORO C LARSON A BALOW J KLIPPEL JH SCOTT D
Citation: Jc. Davis et al., A PILOT-STUDY OF 2-CHLORO-2'-DEOXYADENOSINE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED GLOMERULONEPHRITIS, Arthritis and rheumatism, 41(2), 1998, pp. 335-343
PATHOLOGICAL FINDINGS IN HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Authors: LIM MS STRAUS SE DALE JK FLEISHER TA STETLERSTEVENSON M STROBER W SNELLER MC PUCK JM LENARDO MJ ELENITOBAJOHNSON KSJ LIN AY RAFFELD M JAFFE ES
Citation: Ms. Lim et al., PATHOLOGICAL FINDINGS IN HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, The American journal of pathology, 153(5), 1998, pp. 1541-1550
APOPTOSIS
Authors: FLEISHER TA
Citation: Ta. Fleisher, APOPTOSIS, Annals of allergy, asthma, & immunology, 78(3), 1997, pp. 245-249
T-CELL REGENERATION AFTER CHEMOTHERAPY - IMPLICATIONS FOR IMMUNOTHERAPY IN THE SETTING OF MINIMAL RESIDUAL DISEASE
Authors: MACKALL CL HAKIM FT FLEISHER TA BROWN MR DIMITROV DS GRESS RE
Citation: Cl. Mackall et al., T-CELL REGENERATION AFTER CHEMOTHERAPY - IMPLICATIONS FOR IMMUNOTHERAPY IN THE SETTING OF MINIMAL RESIDUAL DISEASE, European journal of cancer, 33, 1997, pp. 33-33
PRACTICE PARAMETERS FOR THE DIAGNOSIS AND MANAGEMENT OF IMMUNODEFICIENCY (REPRINTED FROM ANNALS OF ALLERGY, ASTHMA, AND IMMUNOLOGY, VOL 76,PG 282-294, 1996)
Authors: SHEARER WT BUCKLEY RH ENGLER RJM FINN AF FLEISHER TA FREEMAN TM HERROD HG LEVINSON AI LOPEZ M RICH RR ROSENFELD SI ROSENWASSER LJ
Citation: Wt. Shearer et al., PRACTICE PARAMETERS FOR THE DIAGNOSIS AND MANAGEMENT OF IMMUNODEFICIENCY (REPRINTED FROM ANNALS OF ALLERGY, ASTHMA, AND IMMUNOLOGY, VOL 76,PG 282-294, 1996), Pediatric asthma, allergy & immunology, 11(1), 1997, pp. 45-64
NO WASH STEP REQUIRED - AUTHORS RESPONSE
Authors: FLEISHER TA MARTI G
Citation: Ta. Fleisher et G. Marti, NO WASH STEP REQUIRED - AUTHORS RESPONSE, Cytometry, 30(6), 1997, pp. 324-325
COMPARATIVE-ANALYSIS OF WHOLE-BLOOD LYSIS METHODS FOR FLOW-CYTOMETRY
Authors: BOSSUYT X MARTI GE FLEISHER TA
Citation: X. Bossuyt et al., COMPARATIVE-ANALYSIS OF WHOLE-BLOOD LYSIS METHODS FOR FLOW-CYTOMETRY, Cytometry, 30(3), 1997, pp. 124-133
SAFETY AND EFFICACY OF STRENGTH TRAINING IN PATIENTS WITH SPORADIC INCLUSION-BODY MYOSITIS
Authors: SPECTOR SA LEMMER JT KOFFMAN BM FLEISHER TA FEUERSTEIN IM HURLEY BF DALAKAS MC
Citation: Sa. Spector et al., SAFETY AND EFFICACY OF STRENGTH TRAINING IN PATIENTS WITH SPORADIC INCLUSION-BODY MYOSITIS, Muscle & nerve, 20(10), 1997, pp. 1242-1248
INTRODUCTION TO DIAGNOSTIC LABORATORY IMMUNOLOGY
Authors: FLEISHER TA TOMAR RH
Citation: Ta. Fleisher et Rh. Tomar, INTRODUCTION TO DIAGNOSTIC LABORATORY IMMUNOLOGY, JAMA, the journal of the American Medical Association, 278(22), 1997, pp. 1823-1834
MANAGEMENT OF NEUTRALIZING ANTIBODY TO CEREDASE IN A PATIENT WITH TYPE-3 GAUCHER-DISEASE
Authors: BRADY RO MURRAY GJ OLIVER KL LEITMAN SF SNELLER MC FLEISHER TA BARTON NW
Citation: Ro. Brady et al., MANAGEMENT OF NEUTRALIZING ANTIBODY TO CEREDASE IN A PATIENT WITH TYPE-3 GAUCHER-DISEASE, Pediatrics, 100(6), 1997, pp. 111-114
PROLONGED PRODUCTION OF NADPH OXIDASE-CORRECTED GRANULOCYTES AFTER GENE-THERAPY OF CHRONIC GRANULOMATOUS-DISEASE
Authors: MALECH HL MAPLES PB WHITINGTHEOBALD N LINTON GF SEKHSARIA S VOWELLS SJ LI F MILLER JA DECARLO E HOLLAND SM LEITMAN SF CARTER CS BUTZ RE READ EJ FLEISHER TA SCHNEIDERMAN RD VANEPPS DE SPRATT SK MAACK CA ROKOVICH JA COHEN LK GALLIN JI
Citation: Hl. Malech et al., PROLONGED PRODUCTION OF NADPH OXIDASE-CORRECTED GRANULOCYTES AFTER GENE-THERAPY OF CHRONIC GRANULOMATOUS-DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(22), 1997, pp. 12133-12138
CLINICAL, IMMUNOLOGICAL, AND GENETIC FEATURES OF AN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME-ASSOCIATED WITH ABNORMAL LYMPHOCYTE APOPTOSIS
Authors: SNELLER MC WANG J DALE JK STROBER W MIDDELTON LA CHOI YN FLEISHER TA LIM MS JAFFE ES PUCK JM LENARDO MJ STRAUS SE
Citation: Mc. Sneller et al., CLINICAL, IMMUNOLOGICAL, AND GENETIC FEATURES OF AN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME-ASSOCIATED WITH ABNORMAL LYMPHOCYTE APOPTOSIS, Blood, 89(4), 1997, pp. 1341-1348
DEVELOPMENT OF ANTIBODIES TO FETAL CALF SERUM WITH ARTHUS-LIKE REACTIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS GIVEN SYNGENEIC LYMPHOCYTE INFUSIONS
Authors: SELVAGGI TA WALKER RE FLEISHER TA
Citation: Ta. Selvaggi et al., DEVELOPMENT OF ANTIBODIES TO FETAL CALF SERUM WITH ARTHUS-LIKE REACTIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS GIVEN SYNGENEIC LYMPHOCYTE INFUSIONS, Blood, 89(3), 1997, pp. 776-779
DISTINCTIONS BETWEEN CD8(-CELL REGENERATIVE PATHWAYS RESULT IN PROLONGED T-CELL SUBSET IMBALANCE AFTER INTENSIVE CHEMOTHERAPY() AND CD4(+) T)
Authors: MACKALL CL FLEISHER TA BROWN MR ANDRICH MP CHEN CC FEUERSTEIN IM MAGRATH IT WEXLER LH DIMITROV DS GRESS RE
Citation: Cl. Mackall et al., DISTINCTIONS BETWEEN CD8(-CELL REGENERATIVE PATHWAYS RESULT IN PROLONGED T-CELL SUBSET IMBALANCE AFTER INTENSIVE CHEMOTHERAPY() AND CD4(+) T), Blood, 89(10), 1997, pp. 3700-3707
PRACTICE PARAMETERS FOR THE DIAGNOSIS AND MANAGEMENT OF IMMUNODEFICIENCY
Authors: SHEARER WT BUCKLEY RH ENGLER RJM FINN AF FLEISHER TA FREEMAN TM HERROD HG LEVINSON AI LOPEZ M RICH RR ROSENFELD SI ROSENWASSER LJ
Citation: Wt. Shearer et al., PRACTICE PARAMETERS FOR THE DIAGNOSIS AND MANAGEMENT OF IMMUNODEFICIENCY, Annals of allergy, asthma, & immunology, 76(3), 1996, pp. 282-294
A PILOT-STUDY OF LOW-DOSE FLUDARABINE IN MEMBRANOUS NEPHROPATHY REFRACTORY TO THERAPY
Authors: TASSIULAS IO BOUMPAS DT VAUGHAN E FLEISHER TA PISCETELLI S KIM Y PUCCINO F BALOW JE AUSTIN HA
Citation: Io. Tassiulas et al., A PILOT-STUDY OF LOW-DOSE FLUDARABINE IN MEMBRANOUS NEPHROPATHY REFRACTORY TO THERAPY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2679-2679
CHARACTERIZATION OF AN IMMUNODEFICIENCY MANIFEST BY SEVERE VIRAL SKININFECTIONS, ECZEMA, AND ASTHMA
Authors: RABIN RL FUSS I PRUSSIN C MCDYER J GARRAUD O NUTMAN TB FLEISHER TA SEDER R STROBER W HOLLAND SM
Citation: Rl. Rabin et al., CHARACTERIZATION OF AN IMMUNODEFICIENCY MANIFEST BY SEVERE VIRAL SKININFECTIONS, ECZEMA, AND ASTHMA, The FASEB journal, 10(6), 1996, pp. 372-372
ORGAN AND BONE MARROW TRANSPLANTATION - PREFACE
Authors: SHEARER WT FLEISHER TA
Citation: Wt. Shearer et Ta. Fleisher, ORGAN AND BONE MARROW TRANSPLANTATION - PREFACE, Immunology and allergy clinics of North America, 16(2), 1996, pp. 11-12
MEASUREMENT OF T-CELL CD69 EXPRESSION - A RAPID AND EFFICIENT MEANS TO ASSESS MITOGEN-INDUCED OR ANTIGEN-INDUCED PROLIFERATIVE CAPACITY IN NORMALS
Authors: MARDINEY M BROWN MR FLEISHER TA
Citation: M. Mardiney et al., MEASUREMENT OF T-CELL CD69 EXPRESSION - A RAPID AND EFFICIENT MEANS TO ASSESS MITOGEN-INDUCED OR ANTIGEN-INDUCED PROLIFERATIVE CAPACITY IN NORMALS, Cytometry, 26(4), 1996, pp. 305-310
TESTING FOR CHRONIC GRANULOMATOUS-DISEASE
Authors: VOWELLS SJ FLEISHER TA MALECH HL
Citation: Sj. Vowells et al., TESTING FOR CHRONIC GRANULOMATOUS-DISEASE, Lancet, 347(9007), 1996, pp. 1048-1049
CHARACTERIZATION OF AN IMMUNODEFICIENCY MANIFEST BY SEVERE VIRAL SKININFECTIONS, ECZEMA, AND ASTHMA
Authors: RABIN RL FUSS I PRUSSIN C MCDYER J GARRAUD O NUTMAN TB FLEISHER TA SEDER R STROBER W HOLLAND SM
Citation: Rl. Rabin et al., CHARACTERIZATION OF AN IMMUNODEFICIENCY MANIFEST BY SEVERE VIRAL SKININFECTIONS, ECZEMA, AND ASTHMA, Journal of allergy and clinical immunology, 97(1), 1996, pp. 861-861
Risultati: 1-25 | 26-50 | 51-53